EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

05.31.10

Gates Foundation Criticised Again for Monopolising Research

Posted in Bill Gates, Finance, Patents at 3:30 am by Dr. Roy Schestowitz

“The chief of malaria for the World Health Organization has complained that the growing dominance of malaria research by the Bill and Melinda Gates Foundation risks stifling a diversity of views among scientists and wiping out the world health agency’s policy-making function.

New York Times, 2008

Summary: Research diversity is being stifled by the Gates Foundation and Gates-funded ‘studies’ spread misconceptions to defend the foundation’s own agenda

THE Gates Foundation is relevant to this Web site because of the role it plays in promoting Microsoft at the expense of software freedom. Today’s post is more closely related to patents than software and we kindly ask readers to revisit some background in order to understand how the Gates Foundation promotes patents on solutions that save people’s lives. It’s an issue of scarcity where any scarcity means loss of life (patents being the expensive component, not manufacturing).

Thanks to PR efforts from the Gates Foundation (which contracts outside agencies to manage its PR), several high-profile publications continue to promote Gates as a saviour of lives, but the truth (or reality) is a little more complicated than that. Some honourable people do talk about it, but the amount of PR typically marginalises them (by sheer volume).

“Big Pharma gets on board with Gates Foundation,” says this new article which points out:

Although most observers of the Gates Foundation highlight the organization’s influence over grantees, it is clear that the world’s largest philanthropy is exerting a strong influence over the pharmaceutical industry.

As we have shown before, the Gates Foundation is a shareholder and a benefactor in this industry. There actually is a conflict of interests. The Gates Foundation is monopolising research while investing (in the shareholder sense) in the companies that benefit from it. As the Indian press put it some days ago:

Should it be just one big idea, the way Bill and Melinda Gates foundation tackles malaria? (Not even a nano comparison in terms of funding).

The investments are selective and they sometimes come with strings attached. This puts a lot of pressure on researchers to comply with the plan of the Gates Foundation and not anything else. Is this the free thinking that research requires? Does that permit diversity of opinions and breadth of exploration?

Here is another new article:

Although the British drug giant known as GSK was heralded by leading health organizations, the driving force behind the disclosure was the Bill & Melinda Gates Foundation.

For those who do not know or remember, the Head of Global Health for the Gates Foundation is from GlaxoSmithKline where he was caught abusing outside researchers who did not agree with him. Charles Grassley was there in the Senate investigating such inexcusable abuse. GlaxoSmithKline is not the only company which is very much inside the Gates Foundation and we gave more examples before (even Monsanto staff is inside the Gates Foundation).

Anyway, this man is called Tachi Yamada and here he is speaking to the press some days ago.

“Grand Challenges Explorations continues to generate unique and creative ways to tackle global health issues,” said Tachi Yamada, president of the Gates Foundation’s Global Health Programme.

To complete his sentence, they strive to generate unique and creative ways to tackle global health issues by paying big pharmaceutical companies after lobbying governments to allocate funds. That does not mean that the Gates Foundation won’t pay anything; it does pay generously, but it also uses its brand power to further boost investment in companies which it has investments in, using taxpayers' money for the most part. Look who is managing some of these funds:

Arabella Philanthropic Investment Advisors, a philanthropy services firm, is working with ultra-wealthy families’ foundations that are looking to make a philanthropic impact with fewer resources. The firm has done work for The Bill and Melinda Gates Foundation, The Mead Family Foundation and for corporations like Caterpillar and Hyatt.

One might say that taxpayers choose to support Gates’ vision, but not everyone agrees. Gates has just produced a self-serving ‘study’ [1, 2] which is being called “absolute nonsense” by someone who is simply not agreeing with the results of such Gates Foundation-funded research. There is an article about it:

FAIR CEO Blasts Kaiser Foundation & Public Agenda HIV/AIDS Study Results as ‘Absolute Nonsense’

The President and CEO of the FAIR Foundation, Dr. Richard Darling, DDS, is publicly denouncing research studies by the Kaiser Family Foundation and Public Agenda which conclude that Americans want more money spent on HIV/AIDS.

[...]

FAIR points out that in addition to the exorbitant federal funding, The Bill & Melinda Gates Foundation has spent approximately $7 billion on global HIV, TB & malaria efforts and billions of additional dollars have been spent on behalf of HIV patients by the collective efforts of pharmaceutical companies, Hollywood AIDS activists and non-profit organizations such as amfAR (American Federation for AIDS Research).

Let’s not forget the Lancet study from Gates — a ‘study’ which was quite widely disputed [1, 2, 3, 4] but is still appearing in the press.

A new study published in the Lancet and funded by the Gates Foundation, looks at rates of decline, and accelerations and decelerations in rates of decline, in mortality in children younger than 5 years for 187 countries from 1970 to 2009.

There is a quiet fight going on between those who advance the Gates agenda and those who understand that his monopolisation of research (and incestuous relationship with particular companies) is a dangerous one for refinement of drugs. It’s simply irresponsible not to report on these issues, however inconvenient it might be to bring them up.

“Gates has created a huge blood-buying operation that only cares about money, not about people.”

AIDS organisation manager, December 2009 (New York Times)

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

2 Comments

  1. Needs Sunlight said,

    May 31, 2010 at 8:20 am

    Gravatar

    It’s not research, don’t call it that. It’s marketing. Please call it correctly. New Speak can be ignored.

    Dr. Roy Schestowitz Reply:

    To an outside observer it would be “weasel words” (calling research “marketing”). Let’s not preach only to the choir and instead make analysis more widely accessible.

    It is possible to show that research is “marketing” without actually stating this directly.

What Else is New


  1. 'Financial Director' Publishes Fake News About the Unitary Patent (UPC)

    Response to some of the latest UPC propaganda, which strives to misinform Financial Directors so as to enrich the author and his firm



  2. Independent and Untainted Web Sites About Patents Are Still Few and Rare

    Commentary about news sources that we rely on, as well as the known pitfalls or the vested interests deeply ingrained in them



  3. The 20% Rule: Patent Trolling Suffers Double-Digit Declines and Patent Troll Technicolor is Collapsing

    Significant demise or total catastrophe for the modus operandi (method) of going after companies with a pile of patents and threats of litigation



  4. US Supreme Court Did Not End Apple's Patent Disputes Over Android (Linux), More Cases Imminent

    An overview of some very recent news regarding the highest court in the United States, which has been dealing with cases that can determine the fate of Free/Open Source software in an age of patent uncertainty and patent thickets surrounding mobility



  5. Links 15/1/2017: Switching From OS X to GNU/Linux, Debian 8.7 Released

    Links for the day



  6. Number of New Patent Cases in the US Fell 25% Last Year, Thanks in Part to the Demise of Software Patent Trolls

    Litigation and prosecutions that rely on patents (failure to resolve disputes, e.g. by sharing ideas, out of court) is down very sharply, in part because firms that make nothing at all (just threaten and/or litigate) have been sinking after much-needed reform



  7. America Invents Act Improved Patent Quality, But Right Wingers Threaten to Make It Worse Again

    The past half a decade saw gradual improvement in assessment of patents in the United States, but there is a growing threat and pressure from the patent microcosm to restore patent maximalism and chaos



  8. PTAB -- Not Deterred by Courts -- Continues to Invalidate a Lot of Software Patents

    The Patent Trial and Appeal Board (PTAB) continues to make progress reforming the patent system by eliminating a lot of patents and setting an example (or new standards) for what is patent-eligible after Alice



  9. EPO Abuses Come Under Fire From Politicians in Luxembourg

    Luxembourg is the latest nation in which concerns about the EPO's serious abuses are brought up not only by the media but also by politicians



  10. Constitutionality as a Barrier and Brexit Barriers to UPC Keep the Whole Pipe Dream Deadlocked

    The UPC is still going nowhere fast, but the demise (or death) of the UPC as we know it must not be taken for granted



  11. Links 14/1/2017: Wine 2.0 RC5 and AryaLinux 2017 Released

    Links for the day



  12. Links 13/1/2017: Linux 4.9.3 and Linux 4.4.42

    Links for the day



  13. Brexit Means No UPC (Unified Patent Court)

    Now that Jo Johnson, Boris Johnson's brother, is officially declared the new minister for intellectual property in the UK everything that Lucy Neville-Rolfe wrote is as solid as paper bag on a rainy London day



  14. Patent Trolls and Software Patents: CloudTrade, Patent Practitioners Density, and Via Licensing

    Software patents armament from a British company, charted concentration of the patent microcosm in the United States, and US-leaning patent trolls that prey on China



  15. Patent Maximalism -- Like Copyright Maximalism -- Relies on Misconceptions and Mass Deception

    The latest examples of discussions about patent scope, courtesy of those looking to benefit financially by pushing such monopolies to the max



  16. Software Patents Still Promoted by IBM and Its Lobbyist (and Former Employee) David Kappos, in Defiance of Much-Needed US Patent Reform

    While the corporate media celebrates IBM as though it's some kind of 'champion' for hoarding patents that it then uses to attack companies which actually grow



  17. Brexit/Trump Effect: Patent Systems With Institutional Corruption and Nepotism

    Rumours about Britain's head of patents (and copyrights etc.) being the brother of the Brexit campaigner and Foreign Minister; meanwhile, on the other side of the Atlantic, rumours suggest that the corrupt judge Rader might be the next head of patents in the United States



  18. Links 11/1/2017: X.Org Server 1.19.1, GitHub's Atom 1.13

    Links for the day



  19. The Patent Microcosm is Already Sucking up to Donald Trump in an Effort to Enrich Itself at Everyone's Expense

    Four new examples of patent maximalists embracing/adopting the pseudo-populist slogan to advance their goals of increasing litigation (which they profit from) and undermining PTAB (which made patents great in the quality sense)



  20. Patent Quality in the United States Can Only be Assessed at the Patent Trial and Appeal Board (PTAB) and the Courts

    The travesty of patent offices in the US and China, where the goal or the accomplishment is measured in terms of the number of patents rather than their quality



  21. Gradual Collapse of Microsoft's Extensive (and External) Patent Trolling Operations

    The President of Microsoft Technology Licensing LLC (patent troll) leaves and the founder of Intellectual Ventures, Microsoft's largest peripheral patent troll, joins Sherpa Technology



  22. No End to Battistelli's Witch-hunts Against the Media, Against Staff, and Against Politicians

    Rumours about the fate of people who are (or have been) criticising Battistelli's reign of terror at the EPO



  23. Links 10/1/2017: Synfig 1.2, Kodachi Linux 3.7

    Links for the day



  24. With Help From the US Supreme Court (Key Cases), Patent Trolls Are Going Away

    The demise of patent trolls in the United States, a trend partly attributable to Alice and other Supreme Court decisions, will likely accelerate soon (later this year) as the future of the Eastern District of Texas courts is at stake



  25. Patent Maximalism on Display: Patent Aggressor IBM Celebrated in the Media

    The patent lust at IBM, which is suing if not just shaking down companies using software patents, earns plenty of puff pieces from the corporate media



  26. FFPE-EPO, the EPO Management's Pet/Yellow Union, Helps Union-Busting (Against SUEPO) in Letter to Notorious Vice-President

    In a letter to Elodie Bergot (as CC) and Željko Topić, who faces many criminal investigations, FFPE-EPO ringleaders reveal their allegiance not to EPO staff but to those who perpetually attack the staff



  27. Links 9/1/2017: Civilization VI Coming to GNU/Linux, digiKam 5.4.0 Released

    Links for the day



  28. Links 9/1/2017: Dell’s Latest XPS 13, GPD Pocket With GNU/Linux

    Links for the day



  29. Update on Patent Trolls and Their Enablers: IAM, Fortress, Inventergy, Nokia, MOSAID/Conversant, Microsoft, Intellectual Ventures, Faraday Future, A*STAR, GPNE, AlphaCap Ventures, and TC Heartland

    A potpourri of reports about some of the world’s worst patent trolls and their highly damaging enablers/facilitators, including Microsoft which claims that it “loves Linux” whilst attacking it with patents by proxy



  30. Mark Summerfield: “US Supreme Court Decision in Alice Looks to Have Eliminated About 75% of New Business Method Patents.”

    Some of the patent microcosm, or those who profit from the bureaucracy associated with patents, responds to claims made by Techrights (that software patents are a dying breed in the US)


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts